Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 01, 2018	Jul. 02, 2017	Jul. 01, 2018	Jul. 02, 2017
Sales by segment of business
Sales	$ 20,830	$ 18,839	$ 40,839	$ 36,605
Percent Change (as a percent)	10.60%		11.60%
U.S.
Sales by segment of business
Sales	$ 10,640	9,726	$ 20,591	19,104
Percent Change (as a percent)	9.40%		7.80%
International
Sales by segment of business
Sales	$ 10,190	9,113	$ 20,248	17,501
Percent Change (as a percent)	11.80%		15.70%
CONSUMER
Sales by segment of business
Sales	$ 3,504	3,478	$ 6,902	6,706
Percent Change (as a percent)	0.70%		2.90%
CONSUMER | U.S.
Sales by segment of business
Sales	$ 1,476	1,487	$ 2,912	2,901
Percent Change (as a percent)	(0.70%)		0.40%
CONSUMER | International
Sales by segment of business
Sales	$ 2,028	1,991	$ 3,990	3,805
Percent Change (as a percent)	1.90%		4.90%
CONSUMER | Baby Care
Sales by segment of business
Sales	$ 456	494	$ 913	949
Percent Change (as a percent)	(7.70%)		(3.80%)
CONSUMER | Baby Care | U.S.
Sales by segment of business
Sales	$ 89	113	$ 186	226
Percent Change (as a percent)	(21.20%)		(17.70%)
CONSUMER | Baby Care | International
Sales by segment of business
Sales	$ 367	381	$ 727	723
Percent Change (as a percent)	(3.70%)		0.60%
CONSUMER | Beauty
Sales by segment of business
Sales	$ 1,109	1,076	$ 2,193	2,057
Percent Change (as a percent)	3.10%		6.60%
CONSUMER | Beauty | U.S.
Sales by segment of business
Sales	$ 637	649	$ 1,248	1,216
Percent Change (as a percent)	(1.80%)		2.60%
CONSUMER | Beauty | International
Sales by segment of business
Sales	$ 472	427	$ 945	841
Percent Change (as a percent)	10.50%		12.40%
CONSUMER | Oral Care
Sales by segment of business
Sales	$ 393	394	$ 772	756
Percent Change (as a percent)	(0.30%)		2.10%
CONSUMER | Oral Care | U.S.
Sales by segment of business
Sales	$ 157	150	$ 314	306
Percent Change (as a percent)	4.70%		2.60%
CONSUMER | Oral Care | International
Sales by segment of business
Sales	$ 236	244	$ 458	450
Percent Change (as a percent)	(3.30%)		1.80%
CONSUMER | OTC
Sales by segment of business
Sales	$ 1,066	1,006	$ 2,138	2,019
Percent Change (as a percent)	6.00%		5.90%
CONSUMER | OTC | U.S.
Sales by segment of business
Sales	$ 454	432	$ 919	909
Percent Change (as a percent)	5.10%		1.10%
CONSUMER | OTC | International
Sales by segment of business
Sales	$ 612	574	$ 1,219	1,110
Percent Change (as a percent)	6.60%		9.80%
CONSUMER | Women's Health
Sales by segment of business
Sales	$ 280	276	$ 523	518
Percent Change (as a percent)	1.40%		1.00%
CONSUMER | Women's Health | U.S.
Sales by segment of business
Sales	$ 4	3	$ 7	6
Percent Change (as a percent)	33.30%		16.70%
CONSUMER | Women's Health | International
Sales by segment of business
Sales	$ 276	273	$ 516	512
Percent Change (as a percent)	1.10%		0.80%
CONSUMER | Wound Care/Other
Sales by segment of business
Sales	$ 200	232	$ 363	407
Percent Change (as a percent)	(13.80%)		(10.80%)
CONSUMER | Wound Care/Other | U.S.
Sales by segment of business
Sales	$ 135	140	$ 238	238
Percent Change (as a percent)	(3.60%)		0.00%
CONSUMER | Wound Care/Other | International
Sales by segment of business
Sales	$ 65	92	$ 125	169
Percent Change (as a percent)	(29.30%)		(26.00%)
PHARMACEUTICAL
Sales by segment of business
Sales	$ 10,354	8,635	$ 20,198	16,880
Percent Change (as a percent)	19.90%		19.70%
PHARMACEUTICAL | U.S.
Sales by segment of business
Sales	$ 5,899	5,010	$ 11,253	9,882
Percent Change (as a percent)	17.70%		13.90%
PHARMACEUTICAL | International
Sales by segment of business
Sales	$ 4,455	3,625	$ 8,945	6,998
Percent Change (as a percent)	22.90%		27.80%
PHARMACEUTICAL | Immunology
Sales by segment of business
Sales	$ 3,338	2,959	$ 6,380	5,889
Percent Change (as a percent)	12.80%		8.30%
PHARMACEUTICAL | Immunology | U.S.
Sales by segment of business
Sales	$ 2,317	2,101	$ 4,317	4,224
Percent Change (as a percent)	10.30%		2.20%
PHARMACEUTICAL | Immunology | International
Sales by segment of business
Sales	$ 1,021	858	$ 2,063	1,665
Percent Change (as a percent)	19.00%		23.90%
PHARMACEUTICAL | Immunology | REMICADE®
Sales by segment of business
Sales	$ 1,320	1,530	$ 2,709	3,202
Percent Change (as a percent)	(13.70%)		(15.40%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S.
Sales by segment of business
Sales	$ 918	1,064	$ 1,834	2,246
Percent Change (as a percent)	(13.70%)		(18.30%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports
Sales by segment of business
Sales	$ 104	127	$ 246	292
Percent Change (as a percent)	(18.10%)		(15.80%)
PHARMACEUTICAL | Immunology | REMICADE® | International
Sales by segment of business
Sales	$ 298	339	$ 629	664
Percent Change (as a percent)	(12.10%)		(5.30%)
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®
Sales by segment of business
Sales	$ 548	439	$ 1,066	867
Percent Change (as a percent)	24.80%		23.00%
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.
Sales by segment of business
Sales	$ 274	230	$ 498	459
Percent Change (as a percent)	19.10%		8.50%
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International
Sales by segment of business
Sales	$ 274	209	$ 568	408
Percent Change (as a percent)	31.10%		39.20%
PHARMACEUTICAL | Immunology | STELARA®
Sales by segment of business
Sales	$ 1,341	983	$ 2,402	1,806
Percent Change (as a percent)	36.40%		33.00%
PHARMACEUTICAL | Immunology | STELARA® | U.S.
Sales by segment of business
Sales	$ 919	680	$ 1,571	1,227
Percent Change (as a percent)	35.10%		28.00%
PHARMACEUTICAL | Immunology | STELARA® | International
Sales by segment of business
Sales	$ 422	303	$ 831	579
Percent Change (as a percent)	39.30%		43.50%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales	$ 129	7	$ 203	14
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales	102	0	168	0
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales	27	7	35	14
PHARMACEUTICAL | Infectious Diseases
Sales by segment of business
Sales	$ 849	792	$ 1,679	1,541
Percent Change (as a percent)	7.20%		9.00%
PHARMACEUTICAL | Infectious Diseases | U.S.
Sales by segment of business
Sales	$ 328	341	$ 661	667
Percent Change (as a percent)	(3.80%)		(0.90%)
PHARMACEUTICAL | Infectious Diseases | International
Sales by segment of business
Sales	$ 521	451	$ 1,018	874
Percent Change (as a percent)	15.50%		16.50%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine
Sales by segment of business
Sales	$ 211	179	$ 421	328
Percent Change (as a percent)	17.90%		28.40%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.
Sales by segment of business
Sales	$ 15	17	$ 29	29
Percent Change (as a percent)	(11.80%)		0.00%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International
Sales by segment of business
Sales	$ 196	162	$ 392	299
Percent Change (as a percent)	21.00%		31.10%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®
Sales by segment of business
Sales	$ 492	454	$ 970	884
Percent Change (as a percent)	8.40%		9.70%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.
Sales by segment of business
Sales	$ 277	278	$ 550	537
Percent Change (as a percent)	(0.40%)		2.40%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International
Sales by segment of business
Sales	$ 215	176	$ 420	347
Percent Change (as a percent)	22.20%		21.00%
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES
Sales by segment of business
Sales	$ 146	159	$ 288	329
Percent Change (as a percent)	(8.20%)		(12.50%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.
Sales by segment of business
Sales	$ 36	46	$ 82	101
Percent Change (as a percent)	(21.70%)		(18.80%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International
Sales by segment of business
Sales	$ 110	113	$ 206	228
Percent Change (as a percent)	(2.70%)		(9.60%)
PHARMACEUTICAL | Neuroscience
Sales by segment of business
Sales	$ 1,528	1,467	$ 3,087	2,964
Percent Change (as a percent)	4.20%		4.10%
PHARMACEUTICAL | Neuroscience | U.S.
Sales by segment of business
Sales	$ 639	620	$ 1,263	1,284
Percent Change (as a percent)	3.10%		(1.60%)
PHARMACEUTICAL | Neuroscience | International
Sales by segment of business
Sales	$ 889	847	$ 1,824	1,680
Percent Change (as a percent)	5.00%		8.60%
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate
Sales by segment of business
Sales	$ 183	181	$ 356	390
Percent Change (as a percent)	1.10%		(8.70%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate | U.S.
Sales by segment of business
Sales	$ 68	76	$ 134	184
Percent Change (as a percent)	(10.50%)		(27.20%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate | International
Sales by segment of business
Sales	$ 115	105	$ 222	206
Percent Change (as a percent)	9.50%		7.80%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / TRINZA® / TREVICTA®
Sales by segment of business
Sales	$ 720	629	$ 1,416	1,233
Percent Change (as a percent)	14.50%		14.80%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / TRINZA® / TREVICTA® | U.S.
Sales by segment of business
Sales	$ 438	387	$ 838	759
Percent Change (as a percent)	13.20%		10.40%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / TRINZA® / TREVICTA® | International
Sales by segment of business
Sales	$ 282	242	$ 578	474
Percent Change (as a percent)	16.50%		21.90%
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®
Sales by segment of business
Sales	$ 188	207	$ 384	414
Percent Change (as a percent)	(9.20%)		(7.20%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.
Sales by segment of business
Sales	$ 80	91	$ 162	186
Percent Change (as a percent)	(12.10%)		(12.90%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International
Sales by segment of business
Sales	$ 108	116	$ 222	228
Percent Change (as a percent)	(6.90%)		(2.60%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales	$ 437	450	$ 931	927
Percent Change (as a percent)	(2.90%)		0.40%
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales	$ 53	66	$ 129	155
Percent Change (as a percent)	(19.70%)		(16.80%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales	$ 384	384	$ 802	772
Percent Change (as a percent)	0.00%		3.90%
PHARMACEUTICAL | Oncology
Sales by segment of business
Sales	$ 2,456	1,727	$ 4,767	3,321
Percent Change (as a percent)	42.20%		43.50%
PHARMACEUTICAL | Oncology | U.S.
Sales by segment of business
Sales	$ 1,085	697	$ 2,018	1,361
Percent Change (as a percent)	55.70%		48.30%
PHARMACEUTICAL | Oncology | International
Sales by segment of business
Sales	$ 1,371	1,030	$ 2,749	1,960
Percent Change (as a percent)	33.10%		40.30%
PHARMACEUTICAL | Oncology | DARZALEX®
Sales by segment of business
Sales	$ 511	299	$ 943	554
Percent Change (as a percent)	70.90%		70.20%
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.
Sales by segment of business
Sales	$ 298	212	$ 562	413
Percent Change (as a percent)	40.60%		36.10%
PHARMACEUTICAL | Oncology | DARZALEX® | International
Sales by segment of business
Sales	$ 213	87	$ 381	141
PHARMACEUTICAL | Oncology | IMBRUVICA®
Sales by segment of business
Sales	$ 620	450	$ 1,207	859
Percent Change (as a percent)	37.80%		40.50%
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.
Sales by segment of business
Sales	$ 250	202	$ 477	392
Percent Change (as a percent)	23.80%		21.70%
PHARMACEUTICAL | Oncology | IMBRUVICA® | International
Sales by segment of business
Sales	$ 370	248	$ 730	467
Percent Change (as a percent)	49.20%		56.30%
PHARMACEUTICAL | Oncology | VELCADE®
Sales by segment of business
Sales	$ 280	290	$ 593	570
Percent Change (as a percent)	(3.40%)		4.00%
PHARMACEUTICAL | Oncology | VELCADE® | U.S.
Sales by segment of business
Sales	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Oncology | VELCADE® | International
Sales by segment of business
Sales	$ 280	290	$ 593	570
Percent Change (as a percent)	(3.40%)		4.00%
PHARMACEUTICAL | Oncology | ZYTIGA®
Sales by segment of business
Sales	$ 909	558	$ 1,754	1,081
Percent Change (as a percent)	62.90%		62.30%
PHARMACEUTICAL | Oncology | ZYTIGA® | U.S.
Sales by segment of business
Sales	$ 486	241	$ 893	474
Percent Change (as a percent)			88.40%
PHARMACEUTICAL | Oncology | ZYTIGA® | International
Sales by segment of business
Sales	$ 423	317	$ 861	607
Percent Change (as a percent)	33.40%		41.80%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales	$ 136	130	$ 270	257
Percent Change (as a percent)	4.60%		5.10%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales	$ 51	42	$ 86	82
Percent Change (as a percent)	21.40%		4.90%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales	$ 85	88	$ 184	175
Percent Change (as a percent)	(3.40%)		5.10%
PHARMACEUTICAL | Pulmonary Hypertension
Sales by segment of business
Sales	$ 665	85	$ 1,250	85
PHARMACEUTICAL | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales	429	37	790	37
PHARMACEUTICAL | Pulmonary Hypertension | International
Sales by segment of business
Sales	236	48	460	48
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®
Sales by segment of business
Sales	311	45	582	45
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.
Sales by segment of business
Sales	180	24	329	24
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International
Sales by segment of business
Sales	131	21	253	21
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER®
Sales by segment of business
Sales	143	26	283	26
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® | U.S.
Sales by segment of business
Sales	71	2	139	2
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® | International
Sales by segment of business
Sales	72	24	144	24
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®
Sales by segment of business
Sales	171	9	311	9
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.
Sales by segment of business
Sales	155	8	279	8
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International
Sales by segment of business
Sales	16	1	32	1
PHARMACEUTICAL | Pulmonary Hypertension | OTHER
Sales by segment of business
Sales	40	5	74	5
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | U.S.
Sales by segment of business
Sales	23	3	43	3
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | International
Sales by segment of business
Sales	17	2	31	2
PHARMACEUTICAL | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales	$ 1,518	1,605	$ 3,035	3,080
Percent Change (as a percent)	(5.40%)		(1.50%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales	$ 1,101	1,214	$ 2,204	2,309
Percent Change (as a percent)	(9.30%)		(4.50%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales	$ 417	391	$ 831	771
Percent Change (as a percent)	6.60%		7.80%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER
Sales by segment of business
Sales	$ 388	413	$ 803	844
Percent Change (as a percent)	(6.10%)		(4.90%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | U.S.
Sales by segment of business
Sales	$ 97	142	$ 229	308
Percent Change (as a percent)	(31.70%)		(25.60%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | International
Sales by segment of business
Sales	$ 291	271	$ 574	536
Percent Change (as a percent)	7.40%		7.10%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®
Sales by segment of business
Sales	$ 679	642	$ 1,257	1,155
Percent Change (as a percent)	5.80%		8.80%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.
Sales by segment of business
Sales	$ 679	642	$ 1,257	1,155
Percent Change (as a percent)	5.80%		8.80%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International
Sales by segment of business
Sales	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®
Sales by segment of business
Sales	$ 215	295	$ 463	579
Percent Change (as a percent)	(27.10%)		(20.00%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.
Sales by segment of business
Sales	$ 169	256	$ 373	503
Percent Change (as a percent)	(34.00%)		(25.80%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International
Sales by segment of business
Sales	$ 46	39	$ 90	76
Percent Change (as a percent)	17.90%		18.40%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®
Sales by segment of business
Sales	$ 236	255	$ 512	502
Percent Change (as a percent)	(7.50%)		2.00%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.
Sales by segment of business
Sales	$ 156	174	$ 345	343
Percent Change (as a percent)	(10.30%)		0.60%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International
Sales by segment of business
Sales	$ 80	81	$ 167	159
Percent Change (as a percent)	(1.20%)		5.00%
MEDICAL DEVICES
Sales by segment of business
Sales	$ 6,972	6,726	$ 13,739	13,019
Percent Change (as a percent)	3.70%		5.50%
MEDICAL DEVICES | U.S.
Sales by segment of business
Sales	$ 3,265	3,229	$ 6,426	6,321
Percent Change (as a percent)	1.10%		1.70%
MEDICAL DEVICES | International
Sales by segment of business
Sales	$ 3,707	3,497	$ 7,313	6,698
Percent Change (as a percent)	6.00%		9.20%
MEDICAL DEVICES | Diabetes Care
Sales by segment of business
Sales	$ 355	421	$ 694	820
Percent Change (as a percent)	(15.70%)		(15.40%)
MEDICAL DEVICES | Diabetes Care | U.S.
Sales by segment of business
Sales	$ 129	160	$ 246	314
Percent Change (as a percent)	(19.40%)		(21.70%)
MEDICAL DEVICES | Diabetes Care | International
Sales by segment of business
Sales	$ 226	261	$ 448	506
Percent Change (as a percent)	(13.40%)		(11.50%)
MEDICAL DEVICES | Diagnostics
Sales by segment of business
Sales	$ 0	0	$ 0	1
MEDICAL DEVICES | Diagnostics | U.S.
Sales by segment of business
Sales	0	0	0	0
MEDICAL DEVICES | Diagnostics | International
Sales by segment of business
Sales	0	0	0	1
MEDICAL DEVICES | Interventional Solutions
Sales by segment of business
Sales	$ 667	573	$ 1,307	1,122
Percent Change (as a percent)	16.40%		16.50%
MEDICAL DEVICES | Interventional Solutions | U.S.
Sales by segment of business
Sales	$ 323	285	$ 627	564
Percent Change (as a percent)	13.30%		11.20%
MEDICAL DEVICES | Interventional Solutions | International
Sales by segment of business
Sales	$ 344	288	$ 680	558
Percent Change (as a percent)	19.40%		21.90%
MEDICAL DEVICES | Orthopaedics
Sales by segment of business
Sales	$ 2,262	2,293	$ 4,512	4,568
Percent Change (as a percent)	(1.40%)		(1.20%)
MEDICAL DEVICES | Orthopaedics | U.S.
Sales by segment of business
Sales	$ 1,332	1,367	$ 2,639	2,726
Percent Change (as a percent)	(2.60%)		(3.20%)
MEDICAL DEVICES | Orthopaedics | International
Sales by segment of business
Sales	$ 930	926	$ 1,873	1,842
Percent Change (as a percent)	0.40%		1.70%
MEDICAL DEVICES | Orthopaedics | HIPS
Sales by segment of business
Sales	$ 360	350	$ 723	702
Percent Change (as a percent)	2.90%		3.00%
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales	$ 211	208	$ 420	417
Percent Change (as a percent)	1.40%		0.70%
MEDICAL DEVICES | Orthopaedics | HIPS | International
Sales by segment of business
Sales	$ 149	142	$ 303	285
Percent Change (as a percent)	4.90%		6.30%
MEDICAL DEVICES | Orthopaedics | KNEES
Sales by segment of business
Sales	$ 382	385	$ 769	783
Percent Change (as a percent)	(0.80%)		(1.80%)
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales	$ 229	236	$ 457	482
Percent Change (as a percent)	(3.00%)		(5.20%)
MEDICAL DEVICES | Orthopaedics | KNEES | International
Sales by segment of business
Sales	$ 153	149	$ 312	301
Percent Change (as a percent)	2.70%		3.70%
MEDICAL DEVICES | Orthopaedics | TRAUMA
Sales by segment of business
Sales	$ 675	643	$ 1,371	1,285
Percent Change (as a percent)	5.00%		6.70%
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales	$ 394	390	$ 801	781
Percent Change (as a percent)	1.00%		2.60%
MEDICAL DEVICES | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales	$ 281	253	$ 570	504
Percent Change (as a percent)	11.10%		13.10%
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER
Sales by segment of business
Sales	$ 845	915	$ 1,649	1,798
Percent Change (as a percent)	(7.70%)		(8.30%)
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | U.S.
Sales by segment of business
Sales	$ 498	533	$ 961	1,046
Percent Change (as a percent)	(6.60%)		(8.10%)
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | International
Sales by segment of business
Sales	$ 347	382	$ 688	752
Percent Change (as a percent)	(9.20%)		(8.50%)
MEDICAL DEVICES | Surgery
Sales by segment of business
Sales	$ 2,515	2,384	$ 4,938	4,655
Percent Change (as a percent)	5.50%		6.10%
MEDICAL DEVICES | Surgery | U.S.
Sales by segment of business
Sales	$ 1,022	1,012	$ 2,015	2,007
Percent Change (as a percent)	1.00%		0.40%
MEDICAL DEVICES | Surgery | International
Sales by segment of business
Sales	$ 1,493	1,372	$ 2,923	2,648
Percent Change (as a percent)	8.80%		10.40%
MEDICAL DEVICES | Surgery | ADVANCED
Sales by segment of business
Sales	$ 1,005	933	$ 1,971	1,810
Percent Change (as a percent)	7.70%		8.90%
MEDICAL DEVICES | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales	$ 402	400	$ 795	792
Percent Change (as a percent)	0.50%		0.40%
MEDICAL DEVICES | Surgery | ADVANCED | International
Sales by segment of business
Sales	$ 603	533	$ 1,176	1,018
Percent Change (as a percent)	13.10%		15.50%
MEDICAL DEVICES | Surgery | GENERAL
Sales by segment of business
Sales	$ 1,169	1,114	$ 2,296	2,188
Percent Change (as a percent)	4.90%		4.90%
MEDICAL DEVICES | Surgery | GENERAL | U.S.
Sales by segment of business
Sales	$ 436	423	$ 859	846
Percent Change (as a percent)	3.10%		1.50%
MEDICAL DEVICES | Surgery | GENERAL | International
Sales by segment of business
Sales	$ 733	691	$ 1,437	1,342
Percent Change (as a percent)	6.10%		7.10%
MEDICAL DEVICES | Surgery | SPECIALTY
Sales by segment of business
Sales	$ 341	337	$ 671	657
Percent Change (as a percent)	1.20%		2.10%
MEDICAL DEVICES | Surgery | SPECIALTY | U.S.
Sales by segment of business
Sales	$ 184	189	$ 361	369
Percent Change (as a percent)	(2.60%)		(2.20%)
MEDICAL DEVICES | Surgery | SPECIALTY | International
Sales by segment of business
Sales	$ 157	148	$ 310	288
Percent Change (as a percent)	6.10%		7.60%
MEDICAL DEVICES | Vision
Sales by segment of business
Sales	$ 1,173	1,055	$ 2,288	1,853
Percent Change (as a percent)	11.20%		23.50%
MEDICAL DEVICES | Vision | U.S.
Sales by segment of business
Sales	$ 459	405	$ 899	710
Percent Change (as a percent)	13.30%		26.60%
MEDICAL DEVICES | Vision | International
Sales by segment of business
Sales	$ 714	650	$ 1,389	1,143
Percent Change (as a percent)	9.80%		21.50%
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales	$ 844	753	$ 1,651	1,436
Percent Change (as a percent)	12.10%		15.00%
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales	$ 320	274	$ 629	530
Percent Change (as a percent)	16.80%		18.70%
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales	$ 524	479	$ 1,022	906
Percent Change (as a percent)	9.40%		12.80%
MEDICAL DEVICES | Vision | SURGICAL
Sales by segment of business
Sales	$ 329	302	$ 637	417
Percent Change (as a percent)	0.00%		0.00%
MEDICAL DEVICES | Vision | SURGICAL | U.S.
Sales by segment of business
Sales	$ 139	131	$ 270	180
Percent Change (as a percent)	0.00%		0.00%
MEDICAL DEVICES | Vision | SURGICAL | International
Sales by segment of business
Sales	$ 190	$ 171	$ 367	$ 237
Percent Change (as a percent)	0.00%		0.00%